Article
High FLT3 expression and IL10 (G1082A) polymorphism in poor overall survival in calla acute lymphoblastic leukemia.
Molecular biology reports - 1 Feb 2013
de Deus Dayse Maria Vasconcelos, de Souza Paulo Roberto Eleutério, Muniz Maria Tereza Cartaxo
Abstract excerpt
Patients with acute lymphoblastic leukemia presenting the immunophenotypic marker CD10+ (calla), usually has treatment profile good. The FLT3 molecular marker is listed as a prognostic factor, an important leukaemogenic marker in acute leukemias, also the polymorphism (G1082A) of the IL10 interleukin can to present pleiotropic effects in many diseases and could is associated to development of ALL. However, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
